World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
21774
World Ranking
18057
National Ranking
1648

David R. Owens publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David R. Owens sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 423 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David R. Owens D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David R. Owens sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David R. Owens is affiliated with Swansea University in the United Kingdom. Their research is situated mainly in the field of Medicine, with a specific focus on Endocrinology, Diabetes and Metabolism. Their scholarly output reflects an emphasis on diabetes-related topics, spanning clinical treatment, disease management, and complications arising from diabetes.

Owens's work has contributed to several important areas within diabetes research. The main topics covered include:

  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Retinal Imaging and Analysis
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Retinal Diseases and Treatments
  • Metabolism, Diabetes, and Cancer

The scientist has authored papers in numerous publication venues, frequently contributing to journals specializing in diabetes and metabolism. Frequent publication venues include:

  • Diabetes Obesity and Metabolism
  • Diabetes & Metabolism
  • Diabetes Research and Clinical Practice
  • Diabetes
  • Diabetes Care

Among the recent papers are:

  • Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses, 2020, Diabetologia
  • Review of methods for detecting glycemic disorders, 2020, Diabetes Research and Clinical Practice
  • Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy, 2023, Cochrane Database of Systematic Reviews
  • Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype, 2020, Nature Reviews Endocrinology
  • The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications, 2020, Diabetes Obesity and Metabolism

Owens has collaborated extensively with several coauthors, indicating active engagement in multidisciplinary research teams. Frequent coauthors include:

  • C Colette
  • Louis Monnier
  • Rebecca Thomas
  • Geremia B. Bolli
  • Stephen D. Luzio

Their body of work addresses complications of diabetes such as vascular issues and proliferative diabetic retinopathy, alongside investigations into glycemic disorder detection and preventive lifestyle interventions for type 2 diabetes mellitus (T2DM). Additionally, there is significant focus on advancements in insulin therapies, emphasizing the development and clinical implications of prandial insulins administered subcutaneously.

Best Publications

  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    Iacopo Olivotto;Artur Oreziak;Roberto Barriales-Villa;Theodore P. Abraham

  • Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.

    D R Owens;P A Coates;S D Luzio;J P Tinbergen

  • The Loss of Postprandial Glycemic Control Precedes Stepwise Deterioration of Fasting With Worsening Diabetes

    Louis Monnier;Claude Colette;Gareth John Dunseath;David Raymond Owens

  • Monomeric insulins and their experimental and clinical implications.

    Jens Brange;David R Owens;Steven Kang;Aage Vølund

  • Insulins today and beyond

    David R Owens;Bernard Zinman;Geremia B Bolli

  • Postprandial Glucose Regulation and Diabetic Complications

    Antonio Ceriello;Markolf Hanefeld;Lawrence Leiter;Louis Monnier

  • Glycaemic variability in diabetes: clinical and therapeutic implications

    Antonio Ceriello;Louis Monnier;David Owens

  • Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

    Reinhard G. Bretzel;Ulrike Nuber;Wolfgang Landgraf;David Raymond Owens

  • Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes

    Louis Monnier;Claude Colette;Anne Wojtusciszyn;Sylvie Dejager

  • Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is it Important? How to Measure it?:

    Louis Monnier;Claude Colette;David Raymond Owens

  • Efficacy and safety of linagliptin in persons with Type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24‐week randomized study1

    David Raymond Owens;R. Swallow;K. A. Dugi;H. J. Woerle

  • IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018.

    R.L. Thomas;S. Halim;S. Gurudas;S. Sivaprasad

  • Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study.

    Francesca Porcellati;Paolo Rossetti;Natalia Ricci Busciantella;Stefania Marzotti

  • New horizons — alternative routes for insulin therapy

    David R. Owens

  • Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses

    Natalie Nanayakkara;Natalie Nanayakkara;Andrea J. Curtis;Stephane Heritier;Adelle M. Gadowski

  • Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus.

    Jiten P. Vora;John Dolben;John D. Dean;David Thomas

  • Postprandial glucose regulation: new data and new implications.

    Lawrence A. Leiter;Antonio Ceriello;Jaime A. Davidson;Markolf Hanefeld

  • Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service

    Rebecca L. Thomas;Frank David John Dunstan;Stephen Denis Luzio;S. R. Chowdhury

  • Anemia and diabetes in the absence of nephropathy.

    Kathrine Jane Craig;John David Williams;Stephen George Riley;Hilary Smith

  • How soon after myocardial infarction should plasma lipid values be assessed

    R E Ryder;T M Hayes;I P Mulligan;J C Kingswood

Frequent Co-Authors

Geremia B. Bolli
Geremia B. Bolli University of Perugia
Antonio Ceriello
Antonio Ceriello MultiMedica
Ian Jones
Ian Jones Cardiff University
Philip Home
Philip Home Newcastle University
Hans-Juergen Woerle
Hans-Juergen Woerle Nestlé (Switzerland)
Jaakko Tuomilehto
Jaakko Tuomilehto University of Helsinki
Peter Boyle
Peter Boyle University of Edinburgh
Marja-Riitta Taskinen
Marja-Riitta Taskinen University of Helsinki
Omer F. Rana
Omer F. Rana Cardiff University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine offers diverse opportunities that go beyond the traditional MD path. Today, several cheapest online mha programs make it possible to step into healthcare leadership and administrative roles without leaving your day job.

Nursing professionals may consider advancing their expertise through some of the best online dnp programs. These doctoral degrees can open doors to specialized clinical or academic positions.

For those interested in the pharmaceutical industry, online pharmacy programs provide flexible options to earn a Doctorate of Pharmacy, potentially leading to high-demand roles in clinics, hospitals, and research.

Additionally, with healthcare delivery increasingly relying on technology and data, earning a health information management degree online prepares graduates for vital jobs in health data management, privacy, and analytics.

These online degree pathways offer affordability, flexibility, and a direct route to rewarding careers outside traditional clinical medicine.

Best Scientists Citing David R. Owens

Trending Scientists

Recently Published Articles